• Vascular endothelial growth factor receptor 2 (VEGFR2) contributes to tamoxifen resistance in estrogen-positive breast cancer patients / T. A. Dronova, N. N. Babyshkina, M. V. Zavyalova [et al.] // Molecular biology. 2021. Vol. 55, № 1. P. 102-108. URL: http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:000902818